Regulation of perioperative immunological changes following laparotomy: Effects of biological response modifier (BRM) on surgical stress

Immunology Letters

Volumn 93, Issue 1, 2004, Pages 33-38

  Ooshiro, Mitsuru ^a   Sugishita, Yu I ^a   Tanaka, Hiroshi ^a   Koide, Kazuki ^a   Nagashima, Makoto ^a   Katoh, Ryoji ^a  

^a TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Animal model; Cytokines; PSK; Surgical stress; Th1 Th2 balance

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 4;

AMBIENT AIR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNITY; IMMUNOCOMPETENCE; LAPAROTOMY; MOUSE; NONHUMAN; OPERATION DURATION; PREOPERATIVE CARE; PRIORITY JOURNAL; SPLEEN; SURGICAL STRESS;

ABDOMINAL CAVITY; ADJUVANTS, IMMUNOLOGIC; ANIMALS; BIOLOGICAL RESPONSE MODIFIERS; CYTOKINES; IMMUNITY; MICE; POSTOPERATIVE PERIOD; STRESS; TIME FACTORS;

EID: 2342559868     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2004.01.008     Document Type: Article

References (19)

1. Buinauskas P., McDonald G.O., Cole W.H. Role of operative stress on the resistance of the experimental animal to inoculated cancer cells. Ann. Surg. 148:1958;642-648
2. Nakazaki H. Preoperative and postoperative cytokines in patients with cancer. Cancer. 70:1992;709-713
3. Romagnani S. Lymphokine production by human T cells in disease states. Ann. Rev. Immunol. 12:1994;227-257
4. Oberholzer A., Oberholzer C., Moldawer L.L. Sepsis syndromes: understanding the role of innate and acquired immunity. Shock. 16:2001;83-96
5. Katoh R., Takenoshita S., Yajima Y., Mogi A., Nagamachi Y. Effects on host of VP therapy with PSK on lung cancer. Biotherapy. 12:1998;667-669
6. Kotani G., Usami M., Kasahara H., Saitoh Y. The relationship of IL-6 to hormonal mediators, fuel utilization, and systemic hypermetabolism after surgical trauma. Kobe J. Med. Sci. 42:1996;187-205
7. Hisano S., Sakamoto K., Ishiko T., Kamohara H., Ogawa M. IL-6 and soluble IL-6 receptor levels change differently after surgery both in the blood and in the operative field. Cytokine. 9:1997;447-452
8. Tung P.H., Smith C.D. Laparoscopic insufflation with room air causes exaggerated interleukin-6 response. Surg. Endosc. 13:1999;473-475
9. Kunieda K., Saji S., Umemoto T., Sugiyama Y., Hatoh T., Yamada M., et al. Effects of PSK on depression of immunocompetency induced by surgical stress. Biotherapy. 9:1995;609-610
10. + T-cell response in gut-associated lymphoid tissue (GALT) of specific-pathogen- free mice. Int. J. Cancer. 70:1997;362-372
11. Matsunaga K., Hosokawa A., Oohara M., Sugita N., Harada M., Nomoto K. Direct action of a protein-bound polysaccharide, PSK, on transforming growth factor-β Immunopharmacology. 40:1998;219-230
12. Pedrinaci S., Algarra I., Garrido F. Protein-bound polysaccharide (PSK) induces cytotoxic activity in the NKL human natural killer cell line. Int. J. Clin. Lab. Res. 29:1999;135-140
13. Hirose K., Zachariae C.O.C., Oppenheim J.J., Matsushima K. Induction of gene expression and production of immunomodulating cytokines by PSK in human peripheral blood mononuclear cells. Lymphokine Res. 9:1990;475-483
14. Iguchi C., Nio Y., Takada H., Yamasawa K., Hirahara N., Toga T., et al. Plant polysaccharide PSK: cytostatic effects on growth and stress; modulating effect on the expression of HLA and adhesion molecules on human gastric and colonic tumor cell surface. Anticancer Res. 21:2001;1007-1014
15. Yefenof E., Gafanovitch I., Oron E., Bar M., Klein E. Prophylactic intervention in radiation-leukemia-virus-induced murine lymphoma by the biological response modifier polysaccharide K. Cancer Immunol. Immunother. 41:1995;389-396
16. Decker D., Schondorf M., Bidlingmaier F., Hirner A., von Ruecker A.A. Surgical stress induces a shift in type-1/type-2 T-helper cell balance, suggesting down-regulation of cell-mediated and up-regulation of antibody-mediated immunity commensurate to the trauma. Surgery. 119:1996;316-325
17. Elenkov I.J., Chrousos G.P., Wilder R.L. Neuroendocrine regulation of IL-12 and TNF-α/IL-10 balance: clinical implications. Ann. N. Y. Acad. Sci. 917:2000;94-105
18. 2-adrenergic receptor by Th1 and Th2 clones: implications for cytokine production and B cell help. J. Immunol. 158:1997;4200-4210
19. Shibata M., Nezu T., Kanou H., Nagata Y., Kimura T., Takekawa M., et al. Immunomodulatory effects of low dose cis-diaminedichloroplatinum (Cisplatin) combined with UFT and PSK in patients with advanced colorectal cancer. Cancer Inv. 20:2002;166-173